The effect zinc supplementation on asthma in Egyptian children Protocol for a subgroup analysis [retrospectively registered]

The effect zinc supplementation on asthma in Egyptian children Protocol for a subgroup analysis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201111000336400

Enrollment

Registered

2011-11-05

Start date

2011-11-30

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma, Zinc, subgroup analysis

Interventions

Zinc at intake - Group b

Vit C at intake - Group a

Omega 3 at intake - Group c

Combined at intake - group d

Placebo at intake - group e

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Age 7 and 10 years Having moderate persistent bronchial asthma

Exclusion criteria

Exclusion criteria: Any chronic diseases other than asthma and rhinitis. Intake of antileukotrienes during the study. Children taking n-3 polyunsaturated fatty acid (PUFA) or antioxidants supplements above the levels recommended for adequate intake, or regularly consumed more than one fish meal per week. Manifestations of vitamin C or Zn deficiency.

Design outcomes

Primary

Measure	Time frame
improvement of the lung functions	—

Countries

Egypt

Contacts

Public ContactMohammed Al-Biltaagi

Ass. Prof of Pediatrics

mbelrem@hotmail.com+20102209797

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026